California State Teachers Retirement System (CalSTRS)’s Aprea Therapeutics APRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-542
Closed -$55K 3077
2021
Q1
$55K Hold
542
﹤0.01% 3087
2020
Q4
$53K Hold
542
﹤0.01% 3055
2020
Q3
$261K Hold
542
﹤0.01% 2599
2020
Q2
$420K Buy
542
+51
+10% +$33.5K ﹤0.01% 2340
2020
Q1
$341K Sell
491
-2
-0.4% -$1.47K ﹤0.01% 2281
2019
Q4
$453K Buy
+493
New +$272K ﹤0.01% 2408

Other funds holding APRE

California State Teachers Retirement System (CalSTRS)'s APRE Position: Q2 2021 in Review

California State Teachers Retirement System (CalSTRS) sold out of Aprea Therapeutics (APRE) in Q2 2021, closing a stake of 542 shares — an estimated $55K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in APRE in Q4 2019 and held it in 6 quarters. The position peaked at $453K in Q4 2019. 50 funds tracked by Wall St. Rank hold APRE as of Q2 2021.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Aprea Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 542 Aprea Therapeutics shares in Q2 2021, an estimated $55K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Aprea Therapeutics in Q4 2019 and held it in 6 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Aprea Therapeutics position peaked at $453K in Q4 2019.
  • 50 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q2 2021.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2021, filed 16 Aug 2021.